Cargando…
Hypoxic response elements and Tet-On advanced double-controlled systems regulate hVEGF(165) and angiopoietin-1 gene expression in vitro()
Angiogenesis in ischemic tissue is a complex and multi-gene event. In the study, we constructed hypoxic response elements (HRE) and the Tet-On advanced double-controlled systems and investigated their effects on the expression of hVEGF(165) and angiopoietin-1 (Ang-1) genes in rat cardiomyocytes expo...
Autores principales: | Zhang, Hao, Dong, Hongyan, Jiang, Bo, Wang, Zheng, Chen, Rui, Zhang, Zhifeng, Zhang, Zhongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597057/ https://www.ncbi.nlm.nih.gov/pubmed/23554691 http://dx.doi.org/10.1016/S1674-8301(11)60027-4 |
Ejemplares similares
-
Short and Long-Term Effects of hVEGF-A(165) in Cre-Activated Transgenic Mice
por: Leppänen, Pia, et al.
Publicado: (2006) -
Protein Expression of Mesenchymal Stem Cells after Transfection of pcDNA3.1(−)-hVEGF(165) by Ultrasound-Targeted Microbubble Destruction
por: Pu, Zhaoxia, et al.
Publicado: (2011) -
Lung tumorigenesis induced by human vascular endothelial growth factor (hVEGF)-A(165) overexpression in transgenic mice and amelioration of tumor formation by miR-16
por: Tung, Yu-Tang, et al.
Publicado: (2015) -
Superparamagnetic iron oxide nanoparticles mediated (131)I-hVEGF siRNA inhibits hepatocellular carcinoma tumor growth in nude mice
por: Chen, Jing, et al.
Publicado: (2014) -
A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies
por: Goedegebuure, Ruben S.A., et al.
Publicado: (2020)